GS0051: Adjuvants for medical purposes; Reagents for medical use; Therapeutic pharmaceutical for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders; Vaccine adjuvants; Vaccines; Adjuvants for use with vaccines; Clinical medical reagents; Human vaccine preparations; Therapeutic vaccines
Case File Event Statements
2/12/2020 - 4 years ago
17 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDType:MAB2
2/12/2020 - 4 years ago
16 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2